HomeNLSP • NASDAQ
add
NLS Pharmaceutics AG
Previous close
$3.43
Day range
$3.23 - $3.58
Year range
$3.00 - $29.08
Market cap
6.06M USD
Avg Volume
428.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.03M | -72.80% |
Net income | -1.02M | 73.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.02M | 72.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 552.76K | -66.53% |
Total assets | 1.19M | -47.43% |
Total liabilities | 10.46M | 59.55% |
Total equity | -9.27M | — |
Shares outstanding | 985.72K | — |
Price to book | -0.36 | — |
Return on assets | -215.08% | — |
Return on capital | 33.98% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.02M | 73.26% |
Cash from operations | -765.25K | 79.02% |
Cash from investing | — | — |
Cash from financing | 592.79K | — |
Net change in cash | -172.46K | 95.27% |
Free cash flow | -636.76K | 72.63% |
About
Founded
2015
Website
Employees
3
